TY  - JOUR

T1  - 9341 CHAMPAIN Study: Initial results from a phase II study of efficacy, safety and tolerability of modified-release hydrocortisones: Chronocort® (Efmody®) versus Plenadren®, in primary adrenal insufficiency

JO  - Journal of the Endocrine Society

UR  - https://eprints.whiterose.ac.uk/id/eprint/218069

PY  - 2024/10/05

AU  - Prete A

AU  - Theiler-Schwetz V

AU  - Arlt W

AU  - Chifu IO

AU  - Harbeck B

AU  - Napier C

AU  - Newell-Price JD

AU  - Rees A

AU  - Reisch N

AU  - Stalla GK

AU  - Aslam N et al

ED  - 

DO  - DOI: 10.1210/jendso/bvae163.131

PB  - The Endocrine Society

VL  - 8

IS  - Supplement_1

Y2  - 2025/11/05

ER  -